Table 1 Clinical background of breast cancer patients
From: Impact of lower co-payments on risk-reducing salpingo-oophorectomy and BRCA testing in Japan
| Â | Pre-coverage period (6 years) N=207 | Post-coverage period (1 year 9 months) N=142 | p |
|---|---|---|---|
Age at diagnosis, mean (SD) | 47 (12.0) | 48 (10.4) | 0.66* |
Age at counseling, mean (SD) | 51 (12.1) | 51 (12.1) | 0.78* |
Hormone sensitivity type | |||
 Luminal (%) | 151 (73.0) | 102 (71.8) | 0.90‡ |
 Triple negative (%) | 38 (18.3) | 25 (17.6) | 0.88‡ |
 HER2 (%) | 12 (5.8) | 13 (9.2) | 0.29‡ |
 Unknown (%) | 6 (2.9) | 2 (1.4) |  |
Bilateral | 45 | 33 | 0.79‡ |
 metachronous | 28 | 20 |  |
 synchronous | 17 | 13 |  |
Family history |  |  | 0.79‡ |
 Yes | 162 | 109 |  |
 No | 45 | 33 |  |
Parity |  |  | 0.80‡ |
 Yes | 154 | 104 |  |
 No | 53 | 38 |  |